Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
University of Utah Research Foundation et al v. Ambry Genetics
Case Number:
2:13-cv-00640
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
February 02, 2015
Myriad Settles 2 More Suits Over Cancer Test Patent
Myriad Genetics Inc. has settled patent infringement litigation with Ambry Genetics Corp. and Counsyl Inc., agreeing to drop claims filed in Utah federal court alleging that Ambry and others infringed Myriad's patents for BRCA cancer gene testing.
-
March 11, 2014
Myriad Loses Bid To Block Ambry Cancer Tests In Patent Row
A Utah federal judge on Monday halted Myriad Genetics Inc.'s quest to block sales of Ambry Genetics Corp. cancer-testing products it claims infringe several of its patents, including five tackled in a landmark U.S. Supreme Court decision last year, ruling that Ambry had raised sufficient questions about the patents' validity.
-
August 27, 2013
Myriad Says It's Immune From Ambry's Antitrust Claims
Myriad Genetics Inc. told a federal court Monday that Ambry Genetics Corp.'s claim that Myriad is using a patent suit against it to monopolize the market for breast cancer gene tests must be dismissed because it is barred by the First Amendment.
-
August 15, 2013
Rivals Fight Myriad Bid For Gene Test Ban In Patent Case
Two companies sued by Myriad Genetics Inc. over genetic testing patents asked a Utah federal judge Wednesday not to impose a preliminary injunction on their competing tests, arguing that Myriad's case is based on a misreading of a recent U.S. Supreme Court ruling on different Myriad patents.
-
August 06, 2013
Ambry Hits Myriad With Antitrust Claim In Gene Test IP Row
Ambry Genetics Corp. claimed Monday that Myriad Genetics Inc. has violated antitrust law and is trying to monopolize the market for breast cancer gene tests by filing a patent suit over Ambry's competing test.
-
July 09, 2013
Myriad Sues Ambry Over Supreme Court-Backed Patents
Myriad Genetics Inc. sued Ambry Genetics Corp. in Utah federal court Tuesday, alleging it launched cancer-testing products that infringe 10 Myriad patents on synthetic DNA and methods of use for two breast cancer genes, including four patents recently upheld by the U.S. Supreme Court.